Literature DB >> 21040709

Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells.

Nundehui Díaz-Lezama1, Mariana Hernández-Elvira, Alejandro Sandoval, Alma Monroy, Ricardo Felix, Eduardo Monjaraz.   

Abstract

Ghrelin is a multifunctional peptide hormone with roles in growth hormone release, food intake and cell proliferation. With ghrelin now recognized as important in neoplastic processes, the aim of this report is to present findings from a series of in vitro studies evaluating the cellular mechanisms involved in ghrelin regulation of proliferation in the PC-3 human prostate carcinoma cells. The results showed that ghrelin significantly decreased proliferation and induced apoptosis. Consistent with a role in apoptosis, an increase in intracellular free Ca(2+) levels was observed in the ghrelin-treated cells, which was accompanied by up-regulated expression of T-type voltage-gated Ca(2+) channels. Interestingly, T-channel antagonists were able to prevent the effects of ghrelin on cell proliferation. These results suggest that ghrelin inhibits proliferation and may promote apoptosis by regulating T-type Ca(2+) channel expression.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040709     DOI: 10.1016/j.bbrc.2010.10.100

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Ghrelin induces gastric cancer cell proliferation, migration, and invasion through GHS-R/NF-κB signaling pathway.

Authors:  Chuang Tian; Lianhai Zhang; Daohu Hu; Jiafu Ji
Journal:  Mol Cell Biochem       Date:  2013-06-27       Impact factor: 3.396

Review 2.  T-type Ca2+ channels and the urinary and male genital tracts.

Authors:  C H Fry; R I Jabr
Journal:  Pflugers Arch       Date:  2014-01-25       Impact factor: 3.657

3.  Development of a [68Ga]-ghrelin analogue for PET imaging of the ghrelin receptor (GHS-R1a).

Authors:  C L Charron; M S McFarland; S Dhanvantari; L G Luyt
Journal:  Medchemcomm       Date:  2018-09-17       Impact factor: 3.597

4.  Ghrelin augments murine T-cell proliferation by activation of the phosphatidylinositol-3-kinase, extracellular signal-regulated kinase and protein kinase C signaling pathways.

Authors:  Jun Ho Lee; Kalpesh Patel; Hyun Jin Tae; Ana Lustig; Jie Wan Kim; Mark P Mattson; Dennis D Taub
Journal:  FEBS Lett       Date:  2014-11-18       Impact factor: 4.124

5.  Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression.

Authors:  Dominik Kraus; Jan Reckenbeil; Matthias Wenghoefer; Helmut Stark; Matthias Frentzen; Jean-Pierre Allam; Natalija Novak; Stilla Frede; Werner Götz; Rainer Probstmeier; Rainer Meyer; Jochen Winter
Journal:  Cell Mol Life Sci       Date:  2015-09-25       Impact factor: 9.261

6.  Upregulation of voltage-gated calcium channel cav1.3 in bovine somatotropes treated with ghrelin.

Authors:  V M Salinas Zarate; A Magdaleno Méndez; B Domínguez Mancera; A Rodríguez Andrade; M Barrientos Morales; P Cervantes Acosta; A Hernández Beltrán; D Romero Salas; J L V Flores Hernández; E Monjaraz Guzmán; D R Félix Grijalva
Journal:  J Signal Transduct       Date:  2013-12-18

Review 7.  Ghrelin and Breast Cancer: Emerging Roles in Obesity, Estrogen Regulation, and Cancer.

Authors:  CheukMan Cherie Au; John B Furness; Kristy A Brown
Journal:  Front Oncol       Date:  2017-01-09       Impact factor: 6.244

8.  Voltage-gated calcium channels: Novel targets for cancer therapy.

Authors:  Nam Nhut Phan; Chih-Yang Wang; Chien-Fu Chen; Zhengda Sun; Ming-Derg Lai; Yen-Chang Lin
Journal:  Oncol Lett       Date:  2017-06-22       Impact factor: 2.967

9.  Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitro by ghrelin.

Authors:  Inge Seim; Penny L Jeffery; Laura de Amorim; Carina M Walpole; Jenny Fung; Eliza J Whiteside; Rohan Lourie; Adrian C Herington; Lisa K Chopin
Journal:  Reprod Biol Endocrinol       Date:  2013-07-23       Impact factor: 5.211

10.  The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.

Authors:  Daniel Hormaechea-Agulla; Manuel D Gahete; Juan M Jiménez-Vacas; Enrique Gómez-Gómez; Alejandro Ibáñez-Costa; Fernando L-López; Esther Rivero-Cortés; André Sarmento-Cabral; José Valero-Rosa; Julia Carrasco-Valiente; Rafael Sánchez-Sánchez; Rosa Ortega-Salas; María M Moreno; Natia Tsomaia; Steve M Swanson; Michael D Culler; María J Requena; Justo P Castaño; Raúl M Luque
Journal:  Mol Cancer       Date:  2017-08-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.